MedTrace Logo

Remifentanil and Atropine for Intubation in Neonates

NCT00815048 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-12-29

No results posted yet for this study

Summary

The investigators hypothesize that the use of a combination of Atropine and Remifentanil will safely facilitate non emergent intubation procedure as effectively as the protocol of Atropine, Fentanyl, and Succinylcholine.

Conditions

  • Endotracheal Intubation

Interventions

DRUG

Atropine/Remifentanil

Atropine 20mcg/kg Remifentanil 3mcg/kg

DRUG

Fentanyl/Atropine/Succinylcholine

Atropine 20mcg/kg Fentanyl 2mcg/kg Succinylcholine 2mg/kg

Sponsors & Collaborators

Principal Investigators

  • Khalid M Alfaleh, MBBS, MSc · King Saud University

  • Karen Choong, FRCPC · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00815048 on ClinicalTrials.gov